Monographie - Amoxicillin sodium / clavulanic acid

Son güncelleme :
19/11/2024

Amoxicillin sodium / clavulanic acid

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Aktil	Macaristan
Amoclan	Suudi Arabistan
Amoklavin	Türkiye
Amoksiklav	Polonya
Amoxclav	Suudi Arabistan
Amplamox	Brezilya
Augmentin	Avusturya, Belçika, Birleşik Arap Emirlikleri, Büyük Britanya, Ekvador, Fransa, Hollanda, İspanya, İsviçre, İtalya, Polonya, Şili, Suudi Arabistan, Türkiye, Yunanistan
Betamox	Portekiz
Clavamox	Avusturya
Clavicin	Malezya, Venezuela
Clavulin	Brezilya
Co-amoxi	İsviçre
Co-Amoxicillin	İsviçre
Curam	Suudi Arabistan, yeni Zelanda
Darzitil	Arjantin
Dibional	Arjantin
Julmentin	Birleşik Arap Emirlikleri
Novamox	Brezilya
Sulbamox	Şili
Tarometin	Polonya
Trifamox	Arjantin, Ekvador, Kolombiya, Meksika

Kaynaklar : Amoxicillin sodium / clavulanic acid

	tip	yayın
186	Dergi	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
889	Dergi	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
1318	Dergi	Ashwin J, Lynn B, Taskis CB. Stability and administration of intravenous Augmentin. Pharm J 1987 ; 238: 116-118.
1357	Dergi	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1746	Dergi	Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C. Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags. EJHP 2010 ; 16, 30-37.
2139	Dergi	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2231	Dergi	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3520	Laboratuar	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratuar	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3545	Laboratuar	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit Mylan SAS 2009
3549	Laboratuar	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratuar	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratuar	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3791	afiş	Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P. Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y. Apifh Congress, Paris November 2014 2014
3824	Dergi	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3948	Dergi	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
4470	Dergi	Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. Continuous versus intermittent infusion of temocillin in intensive care unit patient. Critical care 2005 ; 9(Suppl 1) P37
4524	afiş	Stucki C, Sautter A-M, Bonnabry P. Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 2009
4654	afiş	Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 2021

Mentions Légales